The P2Y purinoceptor in rat brain microvascular endothelial cells couple to inhibition of adenylate cyclase

British Journal of Pharmacology

Volumn 119, Issue 7, 1996, Pages 1385-1392

  Webb, Tania E ^c   Feolde, Erick ^a   Vigne, Paul ^a   Neary, Joseph T ^b   Runberg, Anna ^c   Frelin, Christian ^a   Barnard, Eric A ^c  

^a INSTITUT DE PHARMACOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

2 methylthioATP; Adenylate cyclase inhibition; ATP; C6 2B glioma; P2Y purinoceptors; P2Y1 binding parameters; PPADS; Rat brain capillary endothelium

Indexed keywords

2 CHLOROADENOSINE 5' TRIPHOSPHATE; 2 METHYLTHIOADENOSINE TRIPHOSPHATE; ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; ADENOSINE TRIPHOSPHATE DERIVATIVE; ADENYLATE CYCLASE; BRAIN RECEPTOR; CHOLERA TOXIN; CIBACRON BLUE F3GA; COMPLEMENTARY DNA; CYCLIC AMP; DEOXYADENOSINE TRIPHOSPHATE; MESSENGER RNA; PERTUSSIS TOXIN; PURINE P2Y RECEPTOR; PURINERGIC RECEPTOR BLOCKING AGENT; SULFUR 35; SURAMIN; URIDINE TRIPHOSPHATE;

ANIMAL CELL; ARTICLE; ASTROCYTE; BRAIN CAPILLARY; CONTROLLED STUDY; ENZYME INHIBITION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RADIOASSAY; RAT; RECEPTOR AFFINITY; RECEPTOR BINDING; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM;

EID: 0029800803     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb16050.x     Document Type: Article

References (49)

1. 2 purinoceptor from human erythro leukemia cells. J. Biol. Chem., 271, 18363-18367.
2. 1 purinoceptor. Biochem. Biophvs. Res. Commun., 218, 783-788.
3. BARNARD, E.A., BURNSTOCK, G. & WEBB, T.E. (1994). The G-protein coupled receptors for ATP and other nucleotides: a new receptor family. Trends Pharmacol. Sci., 15, 67-70.
4. 2Y1 purinergic receptor agonists and guanine nucleotides. J. Biol. Chem., 264, 884-890.
5. 2Y-purinergic receptor that inhibits Adenylate Cyclase. J. Pharmacol. Exp. Ther., 267, 1140-1146.
6. 2Y-purinoceptors. Br. J. Pharmacol., 113, 614-620.
7. BOYER, P.D. & STEMPEL, K. (1979). Rapid nucleotide labelling and (18) O exchange probes of intermediate states in electron transport coupled phosphorylation. Methods Enzymol., 55, 245-261.
8. 2U-purinoceptors. Br. J. Pharmacol., 116, 2413-2416.
9. BURNSTOCK, G. (1990). Purinergic mechanisms. In Biological Actions of Extracellular ATP, The Annals of the New York Academy of Sciences, Vol. 603. ed. Dubyak, G.R. & Fedan, J.S. pp. 1-17. New York: The New York Academy of Sciences.
10. BURNSTOCK, G. & KING, B.F. (1996). The numbering of cloned P2 purinoceptors. Drug Devel. Res., (in press).
11. CHEN, Z.P., KRULL, N., XU, S., LEVY, A. & LIGHTMAN, S.L. (1996). Molecular cloning and functional characterisation of a rat pituitary G protein-coupled ATP receptor. Endocrinology, 137, 1833-1840.
12. CHOMCZYNSKI, P. & SACCHI, N. (1987). Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform. Anal. Biochem., 162, 156-159.
13. CULIC, O., SABOLIC, I. & ZANTIC-GRUBISIC, T. (1990). The steowise hydrolysis of adenine nucleotides by ectoenzymes of rat renal brush-border membranes. Biochem. Biophys. Acta, 1030, 143-151.
14. 2-purinergic receptors for extracellular ATP and other nucleotides. Am. J. Physiol., 265, C577-C606.
15. 2 purinoceptor antagonist in mouse vas deferens. Br. J. Pharmacol., 93, 243-245.
16. 2Y purinergic receptors in rat brain microvascular endothelial cells. Br. J. Pharmacol., 115, 1199-1203.
17. 2Y purinergic receptor that couples to phospholipase C. Mol. Pharmacol., 46, 8-14.
18. FREDHOLM, B.B., ABBRACCHIO, M.P., BURNSTOCK, G., DALY, J.W., HARDEN, T.K., JACOBSON, K.A., LEFF, P. & WILLIAMS, M. (1994). Nomenclature and classification of purinoceptors. Pharmacol. Rev., 46, 143-156.
19. 2+ mobilisation in brain capillary endothelial cells. J. Biol. Chem., 268, 8787-8792.
20. 2Y receptor. Biochem. Biophys. Res. Commun., 212, 648-656.
21. JUUL, B., LUSCHER, M.E., AALKJAER, C. & PLESNER, L. (1991). Nucleotide hydrolytic activity of isolated intact rat mesenteric small arteries. Biochim. Biophys. Acta, 1067, 201-207.
22. 2Y purinergic receptor on type 1 astroglia results in inositol phosphate formation and calcium mobilisation. J. Neurochem., 58, 1277-1284.
23. KENAKIN, T., BOND, R.A. & BONNER, T.L. (1991). Definition of pharmacological receptors. Pharmacol. Rev., 44, 351-362.
24. KENAKIN, T. (1995a). Agonist-receptor efficacy I: mechanisms of efficacy and receptor promiscuity. Trends Pharmacol. Sci., 16, 188-192.
25. KENAKIN, T. (1995b). Agonist-receptor efficacy II: agonist trafficking of receptor signals. Trends Pharmacol. Sci., 16, 232-238.
26. 2X purinoceptors be classified pharmacologically? Trends Pharmacol. Sci., 16, 168-173.
27. 1 purinoceptor. Gene, 171, 295-297.
28. LUSTIG, K.D., SHIAU, A.K., BRAKE, A.J. & JULIUS, D. (1993). Expression cloning of an ATP receptor from mouse neuroblastoma cells. Proc. Natl. Acad. Sci. U.S.A., 90, 5113-5117.
29. MOCKETT, B.G., HOUSLEY, G.D. & THORNE, P.R. (1994). Fluorescence imaging of extracellular purinergic receptor sites and putative ecto-ATPase sites on isolated cochlea hair cells. J. Neurosci., 14, 6992-7007.
30. 2U receptors in inositol phosphate response. Circ. Res., 72, 504-510.
31. 2 receptors. Eur. J. Pharmacol., 307, 201-209.
32. MUNSON, P.J. & RODBARD, D. (1980). A versatile computerised approach for the characterisation of ligand binding systems. Anal. Biochem., 107, 220-239.
33. NEARY, J.T., WHITTLEMORE, S.R., ZHU, Q. & NORENBERG, M.D. (1994). Synergistic activation of DNA synthesis in astrocytes by fibroblast growth factor and extracellular ATP. J. Neurochem., 63, 490-494.
34. 2U nucleotide receptor, a target for cystic fibrosis pharmacology. Proc. Natl. Acad. Sci. U.S.A., 91, 3275-3279.
35. PUSKISS, J.R., WILKINSON, G.F. & BOARDER, M.R. (1993). Evidence for a nucleotide receptor on adrenal medullary endothelial cells linked to phospholipase C and phospholipase D. Br. J. Pharmacol., 108, 1031-1037.
36. 2Y-stimulated surfactant phospholipid secretion from isolated alveolar type II cells. Br. J. Pharmacol., 97, 158-162.
37. 2U-purinergic receptor. Am. J. Respir. Cell. Mol. Biol., 12, 27-32.
38. RICHARDSON, A., DEMOLIOU-MASON, C. & BARNARD, E.A. (1992). Guanine nucleotide-binding protein-coupled and -uncoupled states of opioid receptors and their relevance to the determination of subtypes. Proc. Natl. Acad. Sci. U.S.A., 89, 10198-10202.
39. 1-purinoceptor. Br. J. Pharmacol., 118, 167-173.
40. 2Y purinoceptor in the brain. Pharmacol. Toxicol., 76, 302-307.
41. 2Y purinoceptor. Eur. J. Pharmacol. Mol. Pharmacol. Section, 291, 281-289.
42. 2Y purinoceptors. Biochem. Biophys. Res. Commun., 211, 211-218.
43. VIGNE, P., FEOLDE, E., BREITTMAYER, J.P. & FRELIN, C. (1994). Characterisation of the effects of 2-methylthio-ATP and 2-chloro-ATP on brain capillary endothelial cells. Similarities to ADP and differences from ATP. Br. J. Pharmacol., 112, 775-780.
44. 5. Biochem. Biophrs. Res. Commun., 219, 105-110.
45. 1 purinoceptor and localisation of the corresponding mRNA. Cell. Mol. Biol., 40, 437-442.
46. 2Y purinoceptor. FEBS Lett., 324, 219-225.
47. 35S]adenosine 5′-O-(2-thiodsphosphate) to endothelial cells in culture. Biochem. Pharmacol., 49, 1411-1418.
48. 2X-purinoceptor-mediated responses in the rabbit urinary bladder. Br. J. Pharmacol., 110, 1491-1495.
49. ZIGANSHIN, A.U., ZIGANSHINA, L.E., KING, B.F. & BURNSTOCK, G. (1995). Characteristics of ecto-ATPase of Xenopus oocytes and the inhibitory actions of suramin on ATP breakdown. Pflügers Arch., 429, 412-418.